These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 8137725)

  • 1. Neuropeptide-Y potentiates the secretion of vasopressin from the neurointermediate lobe of the rat pituitary gland.
    Larsen PJ; Jukes KE; Chowdrey HS; Lightman SL; Jessop DS
    Endocrinology; 1994 Apr; 134(4):1635-9. PubMed ID: 8137725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. tGLP-1 and release of vasopressin and oxytocin from the isolated rat hypothalamo-neurohypophysial system: effects of a tGLP-1 receptor agonist and antagonist.
    Bojanowska E; Stempniak B
    J Physiol Pharmacol; 2001 Dec; 52(4 Pt 2):781-93. PubMed ID: 11785773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osmotic regulation of neuropeptide Y and its binding sites in the magnocellular hypothalamo-neurohypophysial pathway.
    Larsen PJ; Sheikh SP; Mikkelsen JD
    Brain Res; 1992 Feb; 573(2):181-9. PubMed ID: 1324077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic peptide inhibits neurohypophysial hormones' release in the rat (in vitro and in vivo studies).
    Lewandowska A; Szyburska I; Guzek JW
    J Physiol Pharmacol; 1992 Mar; 43(1):79-88. PubMed ID: 1450436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurokinin A and the neurohypophysial response to melatonin: in vitro studies.
    Juszczak M
    J Physiol Pharmacol; 2002 Dec; 53(4 Pt 2):823-34. PubMed ID: 12510866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyrotropin-releasing hormone (TRH) modulates vasopressin and oxytocin release from the hypothalamo-neurohypophysial system in dehydrated rats.
    Ciosek J; Guzek JW; Orłowska-Majdak M
    J Physiol Pharmacol; 1993 Sep; 44(3):293-302. PubMed ID: 8241530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of prostaglandin synthesis and the release of vasopressin and oxytocin from the rat neurohypophysis: in vitro studies.
    Bojanowska E; Guzek JW
    Exp Clin Endocrinol; 1991; 98(3):213-21. PubMed ID: 1778241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a prostacyclin analogue on the vasopressin and oxytocin secretion in vitro.
    Bojanowska E; Guzek JW
    Acta Physiol Pol; 1990; 41(7):14-21. PubMed ID: 1726600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular calcium and hormone release from nerve endings of the neurohypophysis in the presence of opioid agonists and antagonists.
    Dayanithi G; Stuenkel EL; Nordmann JJ
    Exp Brain Res; 1992; 90(3):539-45. PubMed ID: 1358668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y2 receptors on nerve endings from the rat neurohypophysis regulate vasopressin and oxytocin release.
    Sheikh SP; Feldthus N; Orkild H; Göke R; McGregor GP; Turner D; Møller M; Stuenkel EL
    Neuroscience; 1998 Jan; 82(1):107-15. PubMed ID: 9483507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Centrally administered galanin modifies vasopressin and oxytocin release from the hypothalamo-neurohypophysial system of euhydrated and dehydrated rats.
    Ciosek J; Cisowska A
    J Physiol Pharmacol; 2003 Dec; 54(4):625-41. PubMed ID: 14726616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ontogeny of opioid inhibition of vasopressin and oxytocin release in response to osmotic stimulation.
    Hartman RD; Rosella-Dampman LM; Emmert SE; Summy-Long JY
    Endocrinology; 1986 Jul; 119(1):1-11. PubMed ID: 3720659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relaxin affects the release of oxytocin and vasopressin from the neurohypophysis.
    Dayanithi G; Cazalis M; Nordmann JJ
    Nature; 1987 Feb 26-Mar 4; 325(6107):813-6. PubMed ID: 2434861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurohypophysial response to peptides of the cholecystokinin family: in vivo and in vitro studies.
    Morawska-Barszczewska J; Lewandowska A; Guzek JW
    Pol J Pathol; 1994; 45(2):163-71. PubMed ID: 8062068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galanin and galanin-like peptide modulate vasopressin and oxytocin release in vitro: the role of galanin receptors.
    Wodowska J; Ciosek J
    Neuropeptides; 2014 Dec; 48(6):387-97. PubMed ID: 25464889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of stimulus frequency and potassium channel blockade on the secretion of vasopressin and oxytocin from the neurohypophysis.
    Bondy CA; Gainer H; Russell JT
    Neuroendocrinology; 1987 Sep; 46(3):258-67. PubMed ID: 2443864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin and release of neurohypophysial hormones: in vivo and in vitro studies.
    Guzek JW; Lewandowska A; Stempniak B
    Exp Clin Endocrinol; 1988 Sep; 92(1):43-50. PubMed ID: 3068066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin octapeptide and the daily rhythm of vasopressin and oxytocin release.
    Morawska-Barszczewska J; Guzek JW; Kaczorowska-Skóra J
    Exp Clin Endocrinol Diabetes; 1996; 104(2):164-71. PubMed ID: 8740941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ca2+ clearance mechanisms in neurohypophysial terminals of the rat.
    Sasaki N; Dayanithi G; Shibuya I
    Cell Calcium; 2005 Jan; 37(1):45-56. PubMed ID: 15541463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin, pinealectomy, and release of neurohypophysial hormones: in vitro studies.
    Juszczak M; Stempniak B; Guzek JW
    J Pineal Res; 1992 Jan; 12(1):1-6. PubMed ID: 1564628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.